IFP Advisors’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $113K | Sell |
404
-10
| -2% | -$2.63K | ﹤0.01% | 1894 |
|
|
2026
Q1 | $110K | Sell |
414
-37
| -8% | -$10K | ﹤0.01% | 1781 |
|
|
2025
Q4 | $113K | Sell |
451
-4
| -0.9% | -$1.06K | ﹤0.01% | 1721 |
|
|
2025
Q3 | $131K | Buy |
455
+191
| +72% | +$51.2K | ﹤0.01% | 1517 |
|
|
2025
Q2 | $146K | Sell |
264
-85
| -24% | -$20.7K | ﹤0.01% | 1424 |
|
|
2025
Q1 | $81.3K | Sell |
349
-3
| -0.9% | -$728 | ﹤0.01% | 1644 |
|
|
2024
Q4 | $80.8K | Buy |
352
+259
| +278% | +$59.4K | ﹤0.01% | 1575 |
|
|
2024
Q3 | $20.8K | Sell |
93
-58
| -38% | -$12.7K | ﹤0.01% | 2129 |
|
|
2024
Q2 | $30.8K | Buy |
151
+98
| +185% | +$19.9K | ﹤0.01% | 1884 |
|
|
2024
Q1 | $11.6K | Sell |
53
-4
| -7% | -$881 | ﹤0.01% | 2178 |
|
|
2023
Q4 | $13K | Sell |
57
-51
| -47% | -$10.7K | ﹤0.01% | 2087 |
|
|
2023
Q3 | $21.7K | Sell |
108
-11
| -9% | -$2.32K | ﹤0.01% | 1908 |
|
|
2023
Q2 | $24.6K | Sell |
119
-175
| -60% | -$33.9K | ﹤0.01% | 1913 |
|
|
2023
Q1 | $29.7K | Sell |
294
-643
| -69% | -$132K | ﹤0.01% | 1835 |
|
|
2022
Q4 | $129K | Sell |
937
-373
| -28% | -$72.9K | ﹤0.01% | 1603 |
|
|
2022
Q3 | $175K | Buy |
1,310
+247
| +23% | +$50.6K | ﹤0.01% | 1491 |
|
|
2022
Q2 | $148K | Hold |
1,063
| – | – | ﹤0.01% | 1458 |
|
|
2022
Q1 | $148K | Buy |
1,063
+867
| +442% | +$204K | ﹤0.01% | 1458 |
|
|
2021
Q4 | $54K | Sell |
196
-46
| -19% | -$11.4K | ﹤0.01% | 1521 |
|
|
2021
Q3 | $59K | Sell |
242
-232
| -49% | -$58.5K | ﹤0.01% | 1518 |
|
|
2021
Q2 | $115K | Buy |
474
+160
| +51% | +$36.5K | ﹤0.01% | 1172 |
|
|
2021
Q1 | $70K | Sell |
314
-14
| -4% | -$2.81K | ﹤0.01% | 1315 |
|
|
2020
Q4 | $57K | Sell |
328
-69
| -17% | -$11.9K | ﹤0.01% | 1384 |
|
|
2020
Q3 | $64K | Sell |
397
-102
| -20% | -$16.2K | ﹤0.01% | 1195 |
|
|
2020
Q2 | $68K | Sell |
499
-131
| -21% | -$18.1K | 0.01% | 1074 |
|
|
2020
Q1 | $75K | Buy |
630
+159
| +34% | +$22.9K | 0.01% | 957 |
|
|
2019
Q4 | $70K | Buy |
471
+8
| +2% | +$1.16K | 0.01% | 1108 |
|
|
2019
Q3 | $65K | Buy |
+463
| New | +$67.6K | ﹤0.01% | 1250 |
|
|
2019
Q1 | $69K | Sell |
510
-749
| -59% | -$92.3K | 0.01% | 834 |
|
|
2018
Q4 | $135K | Buy |
1,259
+728
| +137% | +$97.5K | 0.01% | 1042 |
|
|
2018
Q3 | $79K | Sell |
531
-449
| -46% | -$68.3K | ﹤0.01% | 1624 |
|
|
2018
Q2 | $151K | Sell |
980
-18
| -2% | -$2.72K | 0.01% | 1234 |
|
|
2018
Q1 | $137K | Hold |
998
| – | – | 0.01% | 1193 |
|
|
2017
Q4 | $137K | Sell |
998
-284
| -22% | -$37.5K | 0.01% | 1202 |
|
|
2017
Q3 | $166K | Sell |
1,282
-52
| -4% | -$6.94K | 0.01% | 1255 |
|
|
2017
Q2 | $177K | Buy |
1,334
+609
| +84% | +$74.6K | 0.01% | 1197 |
|
|
2017
Q1 | $89K | Buy |
725
+2
| +0.3% | +$237 | ﹤0.01% | 1557 |
|
|
2016
Q4 | $80K | Sell |
723
-212
| -23% | -$23.6K | ﹤0.01% | 1587 |
|
|
2016
Q3 | $110K | Buy |
935
+125
| +15% | +$14.7K | 0.01% | 1309 |
|
|
2016
Q2 | $91K | Buy |
810
+300
| +59% | +$32.3K | 0.01% | 1398 |
|
|
2016
Q1 | $69K | Sell |
510
-110
| -18% | -$10.5K | 0.01% | 834 |
|
|
2015
Q4 | $66K | Buy |
+620
| New | +$64K | ﹤0.01% | 1435 |
|
Other funds holding LH
IFP Advisors's LH Position: Q2 2026 in Review
IFP Advisors reduced its Labcorp (LH) stake by 2.4% in Q2 2026, selling an estimated $2.63K and leaving 404 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #1894.
IFP Advisors first reported a position in LH in Q4 2015 and has held it in 42 quarters since. The position peaked at $177K in Q2 2017. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- IFP Advisors held 404 shares of Labcorp worth $113K as of Q2 2026.
- IFP Advisors sold 10 Labcorp shares in Q2 2026, an estimated $2.63K.
- Labcorp made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #1894 holding.
- IFP Advisors first reported a position in Labcorp in Q4 2015 and has held it in 42 quarters since.
- IFP Advisors's Labcorp position peaked at $177K in Q2 2017.
- 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.